norethindrone has been researched along with Cystadenoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, RE; Marrs, RP; Paulson, RJ; Sauer, MV; Serafini, PC | 1 |
| Fuller, ME | 1 |
2 other study(ies) available for norethindrone and Cystadenoma
| Article | Year |
|---|---|
Detection and management of pathological, non-palpable, cystic adnexal masses.
Topics: Adnexal Diseases; Adult; Contraceptives, Oral, Combined; Cystadenoma; Cysts; Drug Combinations; Endometriosis; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Laparoscopy; Mestranol; Norethindrone; Norgestrel; Teratoma; Ultrasonography; Uterine Neoplasms | 1990 |
Oral contraceptive therapy for differentiating ovarian cysts.
Topics: Adult; Contraceptives, Oral; Cystadenoma; Diagnosis, Differential; Endometriosis; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Mestranol; Norethindrone; Norethynodrel; Ovarian Cysts; Ovarian Diseases; Ovarian Neoplasms; Pituitary Gland | 1971 |